Kadmon Holdings Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Kadmon Holdings Inc.

Kadmon Holdings Inc. | Key People and Executives

Anastasios G. Konidaris

Independent Director

Steven Meehan

Independent Director

Susan Wiviott

Independent Director

Dennie Dixon Boardman

Independent Director

Eugene Andrew Bauer

Independent Director

Harlan W. Waksal

President, Chief Executive Officer & Director

Konstantin Poukalov

Executive VP, Chief Financial & Accounting Officer

John L. Ryan

Chief Medical Officer & Executive Vice President

Steven N. Gordon

Chief Administrative, Compliance & Legal Officer

Gregory S. Moss

Senior Vice President & Deputy General Counsel

Bart M. Schwartz

Chairman

Anastasios G. Konidaris

Independent Director

Steven Meehan

Independent Director

Susan Wiviott

Independent Director

Dennie Dixon Boardman

Independent Director

Eugene Andrew Bauer

Independent Director

View Profile

Address	450 East 29th Street New York New York 10016 United States
Employees	-
Website	http://www.kadmon.com
Updated	07/08/2019
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N.